HRP20020735A2 - Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient - Google Patents

Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient

Info

Publication number
HRP20020735A2
HRP20020735A2 HRP20020735A HRP20020735A2 HR P20020735 A2 HRP20020735 A2 HR P20020735A2 HR P20020735 A HRP20020735 A HR P20020735A HR P20020735 A2 HRP20020735 A2 HR P20020735A2
Authority
HR
Croatia
Prior art keywords
hydroxybutylidene
amino
active ingredient
direct compression
bisphosphonic acid
Prior art date
Application number
Other languages
English (en)
Inventor
Dagmar Jaueprovs
Original Assignee
Leciva
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5471285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20020735(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leciva filed Critical Leciva
Publication of HRP20020735A2 publication Critical patent/HRP20020735A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HRP20020735 2000-07-11 2001-06-29 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient HRP20020735A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20002567A CZ20002567A3 (cs) 2000-07-11 2000-07-11 Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
PCT/CZ2001/000037 WO2002003963A1 (en) 2000-07-11 2001-06-29 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1, 1-bisphosphonic acid as active ingredient

Publications (1)

Publication Number Publication Date
HRP20020735A2 true HRP20020735A2 (en) 2004-12-31

Family

ID=5471285

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20020735 HRP20020735A2 (en) 2000-07-11 2001-06-29 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient

Country Status (17)

Country Link
US (1) US7198802B2 (cs)
EP (1) EP1299088B1 (cs)
AT (1) ATE331502T1 (cs)
AU (1) AU2001270454A1 (cs)
BG (1) BG107520A (cs)
CA (1) CA2415630A1 (cs)
CZ (1) CZ20002567A3 (cs)
DE (1) DE60121166D1 (cs)
EE (1) EE200300017A (cs)
HR (1) HRP20020735A2 (cs)
HU (1) HUP0301072A3 (cs)
PL (1) PL360872A1 (cs)
RU (1) RU2279273C2 (cs)
SK (1) SK283249B6 (cs)
UA (1) UA73784C2 (cs)
WO (1) WO2002003963A1 (cs)
YU (1) YU77702A (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6827718B2 (en) 2001-08-14 2004-12-07 Scimed Life Systems, Inc. Method of and apparatus for positioning and maintaining the position of endoscopic instruments
EP1499295A4 (en) * 2002-04-05 2006-04-05 Penwest Pharmaceuticals Co EXTENDED RELEASE METOPROLOL FORMULATIONS
GR1004331B (el) * 2002-10-07 2003-09-05 Verisfield (Uk) Ltd Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας αλενδρονικου οξεος
WO2006018033A1 (en) * 2004-08-20 2006-02-23 Mepha Ag Formulations of bisphosphonates
WO2006046100A1 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Pharmaceutical composition of alendronic acid
WO2006054165A1 (en) * 2004-11-19 2006-05-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of alendronic acid and processes for their preparation
JP5424642B2 (ja) * 2005-10-27 2014-02-26 ニクリス アーゲー インプラント及びその製造方法
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
BRPI0918408A2 (pt) * 2008-08-22 2015-11-24 Wockhardt Research Center composição farmacêutica de dose oral unitária simples compreendendo levodopa, carbidopa e entacapona ou sais das mesmas
EA201190243A1 (ru) * 2009-05-19 2013-01-30 Гриндекс, Э Джоинт Сток Кампани Стабильная фармацевтическая композиция флударабина фосфата
WO2011074961A1 (en) 2009-12-18 2011-06-23 Frieslandcampina Nederland Holding B.V. Co-processed tablet excipient composition its preparation and use
US20240350414A1 (en) 2021-08-25 2024-10-24 Basf Se Direct tableting auxiliary composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358941A (en) 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
SK281193B6 (sk) * 1993-05-15 2001-01-18 Roche Diagnostics Gmbh Tableta so zlepšenou biodostupnosťou účinnej látky, kyseliny klodrónovej, spôsob jej výroby a použitie mikrokryštalickej celulózy
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
WO1998042379A2 (en) * 1997-03-26 1998-10-01 Sepracor Inc. Chemically and thermally stable norastemizole formulations
PT1268453E (pt) * 2000-04-07 2006-10-31 Pfizer Prod Inc Metabolitos de agonista/antagonista de estrogenio

Also Published As

Publication number Publication date
DE60121166D1 (de) 2006-08-10
CZ289261B6 (cs) 2001-12-12
RU2279273C2 (ru) 2006-07-10
EP1299088A1 (en) 2003-04-09
HUP0301072A3 (en) 2005-07-28
YU77702A (sh) 2006-05-25
CA2415630A1 (en) 2002-01-17
CZ20002567A3 (cs) 2001-12-12
ATE331502T1 (de) 2006-07-15
AU2001270454A1 (en) 2002-01-21
EP1299088B1 (en) 2006-06-28
SK283249B6 (sk) 2003-04-01
SK5112001A3 (en) 2002-02-05
BG107520A (bg) 2003-06-30
EE200300017A (et) 2004-10-15
UA73784C2 (en) 2005-09-15
PL360872A1 (en) 2004-09-20
US7198802B2 (en) 2007-04-03
HUP0301072A2 (hu) 2003-08-28
WO2002003963A1 (en) 2002-01-17
US20030161878A1 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
NZ507271A (en) Fast disintegrating tablets
HRP20020735A2 (en) Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient
MY148680A (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
MY154010A (en) Rapidly disintegrable solid preparation
AU2509895A (en) Fluoxetine pharmaceutical formulations
JP2002511411A5 (cs)
CA2422359A1 (en) Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds
PT1317419E (pt) Compostos e composições de ácido cianofenoxicarboxílico para administrar agentes activos
CA2382098A1 (en) Sustained-release, oral pharmaceutical forms of administration
EA200000584A2 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
WO2003037860A3 (en) Purine analogs having hsp90-inhibiting activity
IT1271904B (it) Complesso di calcio per arma da fuoco
MXPA04005105A (es) Formulaciones de acitromicina directamente compresibles.
CA2200568A1 (fr) Association therapeutique vitamino-calcique sous forme galenique unitaire de comprimes, son procede d'obtention et son utilisation
AU2002218746A1 (en) Composition comprising folic acid and zinc for improving male fertility
AU4249700A (en) Hydroxamic acid derivative
CA2326339A1 (en) Use of dexmedetomidine for icu sedation
RU2003102448A (ru) Таблетка, получаемая непосредственным прессованием, содержащая 4-амино-1-гидроксибутилиден-1,1-бисфосфоновую кислоту в качестве активного ингредиента
USD446533S1 (en) Videoconferencing tracking camera
CA2311024A1 (en) Pharmaceutical composition for oral administration of chelating agents
CA2399709A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
AP9801350A0 (en) Parasitical formulations.
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
MD1473F2 (en) Antiherpetic remedy
USD460289S1 (en) Machinery cabinet

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: ZENTIVA, A.S., CZ

ODBC Application rejected